-- 根據週二提交給香港交易所的文件,中國新高等教育集團(HKG:2001)截至2月28日的六個月業績顯示,歸屬於母公司名下的淨利潤為4.723億元人民幣,較上年同期的4.693億元增長0.6%。 該校營運商的股價在周三下午的交易中上漲了1%。 每股盈餘從上年同期的0.30元人民幣下滑至0.24元。 總收入從去年同期的14.1億元成長2.6%至14.5億元人民幣,主要得益於學費和住宿費收入的成長。
Related Articles
RBC Upgrades Tamboran Resources to Outperform From Sector Perform, Raises Price Target to $55 From $38, Keeps Speculative Risk
Tamboran Resources (TBN) has an average rating of buy and mean price target of $57.40 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Shanghai Pharmaceuticals' Profit Climbs 6.4% in Q1
Shanghai Pharmaceuticals (SHA:601607, HKG:2607) recorded a 6.4% rise in attributable profit in the first quarter of 2026 to 1.42 billion yuan from 1.33 billion yuan a year prior, according to a Wednesday Hong Kong bourse filing.The pharma company's earnings per share rose to 0.3823 yuan from 0.3595 yuan in the corresponding period of the previous fiscal year.Revenue jumped 6.4% to 75.3 billion yuan from 70.8 billion yuan in the year-ago period.